
SAB Biotherapeutics, Inc.
USD3.88
-0.03 (-0.64%)
CEO
Samuel J. Reich
IPO Date
2021-02-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.90
Prev. Close
$3.90
Day Low
$3.87
Day High
$3.98
52W Low
$1.70
52W High
$6.60
Market Cap
$0.04B
Volume
0.18M
| 12 May 2026 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 11 May 2026 | Rodman & Renshaw | Buy | Buy | maintain |
| 11 Mar 2026 | Chardan Capital | Buy | Buy | maintain |
| 10 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 18 Dec 2025 | Chardan Capital | Buy | Buy | maintain |
| 17 Nov 2025 | Chardan Capital | Buy | Buy | maintain |
| 19 Sept 2025 | Chardan Capital | Buy | Buy | maintain |